TA

Tariq Ahmad Sheikh

Director Director DIN 06432519
DIN 06432519 First appointment Dec 2012 Primary industry General Business
View timeline Unlock full profile Investments · shareholding · contact details
Current companies 0 active board seats
Past companies 1 historical roles
Total affiliations 1 Since Dec 2012
Shareholding value Locked Premium profile

About Tariq Ahmad Sheikh

Tariq Ahmad Sheikh has 13 years in corporate governance. Holds Director role. Formerly with 1 company. Engaged in General Business. Contributes to corporate operations.

DIN 06432519
Primary Designation Director
First Appointment 28 Dec 2012
Oldest Company Age 13 yrs

Current companies

No current companies available.

Previous companies

Company Designation Appointment Founded Status
Cyclops Pharma Private Limited U24110JK2012PTC003762
Director 28 Dec 2012 2012 Strike Off

Explore Director's current and past company associations Uncover their professional journey today!

Directorship timeline

Open interactive timeline →
Cyclops Pharma Private Limited
Premium access

Shareholding and investment profile for Tariq Ahmad Sheikh

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Tariq Ahmad Sheikh

Tariq Ahmad Sheikh has 13 years in corporate governance. Holds Director role. Formerly with 1 company. Engaged in General Business. Contributes to corporate operations.

Tariq Ahmad Sheikh is associated with 0 companies as Director.

Tariq Ahmad Sheikh has expertise in General Business.

Tariq Ahmad Sheikh has 13 years in corporate governance.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available